Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Dm1, Maytansinoid
2. Dm4, Maytansinoid
3. Dmmo Maytansine
4. Dmmo-maytansine
5. Emtansine
6. Maitansine
7. Maytansine
8. Maytansinoid Dm1
9. Maytansinoid Dm4
10. N2'-deacetyl-n2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine
11. Ravtansine
12. Soravtansine
1. Maytansinoid Dm 1
2. Maytansinoid Dm1
3. 139504-50-0
4. Mertansine (dm1)
5. N2'-deacetyl-n2'-(3-mercapto-1-oxopropyl)-maytansine
6. Ddz29hgh0e
7. Dm1
8. Dm 1
9. [(1s,2r,3s,5s,6s,16e,18e,20r,21s)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] (2s)-2-[methyl(3-sulfanylpropanoyl)amino]propanoate
10. Maytansine, N2'-deacetyl-n2'-(3-mercapto-1-oxopropyl)-
11. N2'-deacetyl-n2'-(3-mercapto-1-oxopropyl)-maytansine, L-
12. Dm1 [maytansinoid]
13. Dm 1 [maytansinoid]
14. Unii-ddz29hgh0e
15. Mertasine
16. Dm1;maytansinoid
17. Maytansinoid Dm1
18. Maytansinoid Dm1 [mi]
19. Chembl4802230
20. Schembl13558634
21. Chebi:82755
22. Mfcd28398157
23. S6773
24. Zinc95627837
25. Cs-5804
26. Da-48536
27. Hy-19792
28. J3.653.420f
29. Q4515649
30. (1s,2r,3s,5s,6s,16e,18e,20r,21s)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1(10,14).0(3,5)]hexacosa-10(26),11,13,16,18-pentaen-6-yl (2s)-2-[methyl(3-sulfanylpropanoyl)amino]propanoate
31. (3s)-3-o-de[2-(acetylmethylamino)-1-oxopropyl]-3-o-[(2s)-2-(methyl 3-mercaptopropanoylamino)propanoyl]maytansine
| Molecular Weight | 738.3 g/mol |
|---|---|
| Molecular Formula | C35H48ClN3O10S |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 8 |
| Exact Mass | 737.2748936 g/mol |
| Monoisotopic Mass | 737.2748936 g/mol |
| Topological Polar Surface Area | 158 Ų |
| Heavy Atom Count | 50 |
| Formal Charge | 0 |
| Complexity | 1340 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Tubulin Modulators
Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)
ABOUT THIS PAGE
15
PharmaCompass offers a list of Mertansine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mertansine manufacturer or Mertansine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mertansine manufacturer or Mertansine supplier.
PharmaCompass also assists you with knowing the Mertansine API Price utilized in the formulation of products. Mertansine API Price is not always fixed or binding as the Mertansine Price is obtained through a variety of data sources. The Mertansine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mertansine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mertansine, including repackagers and relabelers. The FDA regulates Mertansine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mertansine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mertansine supplier is an individual or a company that provides Mertansine active pharmaceutical ingredient (API) or Mertansine finished formulations upon request. The Mertansine suppliers may include Mertansine API manufacturers, exporters, distributors and traders.
click here to find a list of Mertansine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mertansine DMF (Drug Master File) is a document detailing the whole manufacturing process of Mertansine active pharmaceutical ingredient (API) in detail. Different forms of Mertansine DMFs exist exist since differing nations have different regulations, such as Mertansine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mertansine DMF submitted to regulatory agencies in the US is known as a USDMF. Mertansine USDMF includes data on Mertansine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mertansine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mertansine suppliers with USDMF on PharmaCompass.
Mertansine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mertansine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mertansine GMP manufacturer or Mertansine GMP API supplier for your needs.
A Mertansine CoA (Certificate of Analysis) is a formal document that attests to Mertansine's compliance with Mertansine specifications and serves as a tool for batch-level quality control.
Mertansine CoA mostly includes findings from lab analyses of a specific batch. For each Mertansine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mertansine may be tested according to a variety of international standards, such as European Pharmacopoeia (Mertansine EP), Mertansine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mertansine USP).
